Ajanta Pharma consolidated net profit rises 18.40% in the March 2026 quarter

Sales rise 21.47% to Rs 1421.64 crore

Net profit of Ajanta Pharma rose 18.40% to Rs 266.70 crore in the quarter ended March 2026 as against Rs 225.26 crore during the previous quarter ended March 2025. Sales rose 21.47% to Rs 1421.64 crore in the quarter ended March 2026 as against Rs 1170.41 crore during the previous quarter ended March 2025.

For the full year,net profit rose 14.73% to Rs 1056.00 crore in the year ended March 2026 as against Rs 920.39 crore during the previous year ended March 2025. Sales rose 17.31% to Rs 5452.86 crore in the year ended March 2026 as against Rs 4648.10 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	1421.64	1170.41	21	5452.86	4648.10	17
OPM %	23.45	25.39	-	25.58	27.10	-
PBDT	392.48	309.19	27	1550.79	1333.27	16
PBT	347.11	269.41	29	1377.65	1189.16	16
NP	266.70	225.26	18	1056.00	920.39	15

Powered by Capital Market - Live News